2 days ago
Australia's CSL eyes reduction of one-third of R&D workforce, AFR reports
(Reuters) -Australian pharmaceutical giant CSL could be looking to lay off around one-third of its research and development staff, the Australian Financial Review (AFR) reported on Monday, citing an unnamed source.
CSL did not immediately respond to a Reuters request for comment.
CSL's head of research and development, Bill Mezzanotte, briefed staff on the move earlier this month but the details will not be outlined to the market until the company releases full-year results on August 19, AFR added.
"We are streamlining the R&D organisation to foster collaboration, reduce duplication and improve efficiencies, and we are simplifying our operating mode," the media outlet said, citing a CSL spokesman.
